Lamotrigine (Lamictal) 5 mg dispersible tablets: Supply issue resolved
GSK, the supplier, advised us of a potential supply issue with lamotrigine (Lamictal) 5 mg dispersible tablets, caused by serious sea freight delays due to events in the Red Sea.
7 February 2024 update
The air freighted stock has arrived in Aotearoa New Zealand. It will be released to wholesalers in due course.
Affected product
We understand that some stock of Lamictal 5 mg dispersible tablets was still in the supply chain. Pharmacies can check with their wholesalers regarding stock status.
Lamotrigine
- Presentation: Tab dispersible 5 mg
- Brand: Lamictal
- Pharmacode: 2056143
- Subsidy: $50.00
- Measure / Qty: per 30
Schedule listing for Lamictal(external link)
The 2 mg Lamictal dispersible tablet is unaffected. The Logem brand is unaffected.
Supply was air freighted
To reduce the risk of an issues, GSK air freighted stock to Aotearoa New Zealand. This has arrived and will be released to wholesalers in the week ending 9 February. It can take 1 to 2 weeks between stock becoming available at the supplier before it reaches pharmacies.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)